Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-27

Clinical Trial Update: IUS Predicts Upadacitinib Efficacy in Patients With Moderate to Severe Crohn's Disease:a Prospective Study

View source ↗

Summary

A prospective study suggests intestinal ultrasound predictors may forecast the efficacy of upadacitinib in patients with moderate-to-severe Crohn's disease. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Upadacitinib (upadacitinib)

Snippet

Sponsor: The Third Xiangya Hospital of Central South University | Conditions: Crohn's Disease, Upadacitinib | Status: UNKNOWN